Carter's, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDCarter's, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 81), indicating clear outperformance against the broad market. Earnings contraction of 7% provides fundamental context to the price action. Investors should exercise caution due to high volatility (54% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $39.91 | +4.17% | ABOVE |
| 50 SMA | $37.53 | +10.75% | ABOVE |
| 100 SMA | $37.04 | +12.22% | ABOVE |
| 150 SMA | $35.68 | +16.50% | ABOVE |
| 200 SMA | $34.36 | +20.99% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CRI in an uptrend right now?
CRI has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, CRI is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is CRI overbought or oversold?
CRI's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is CRI outperforming the market?
CRI has a Relative Strength (RS) Rating of 81 out of 99. Yes, CRI is a market leader, outperforming 81% of all stocks over the past 12 months.
Where is CRI in its 52-week range?
CRI is trading at $41.57, which is 94% of its 52-week high ($44.44) and 86% above its 52-week low ($23.38).
How volatile is CRI?
CRI has a Beta of 1.12 and 52-week volatility of 54%. It's more volatile than the S&P 500 - expect bigger swings.